Table A.2.

Summary statistics of total chronic dietary exposure to azoxystrobin across European dietary surveys (post‐marketing scenario)

Level of exposurea	Age class	N	Total chronic dietary exposure (% ADI)
			Minimum		Median		Maximum
			LB	UB	LB	UB	LB	UB
Mean	Infants (3–6 months)	3	0.00	0.33	0.01	0.40	0.01	0.49
	Infants (6–12 months)	6	0.01	0.41	0.02	0.46	0.04	0.59
	Toddlers	10	0.02	0.44	0.03	0.53	0.05	0.66
95th percentile	Infants (3–6 months)	2	0.02	0.66	0.03	0.80	0.04	0.94
	Infants (6–12 months)	5	0.03	0.68	0.04	0.80	0.11	0.89
	Toddlers	7	0.05	0.76	0.06	0.80	0.11	0.89
97.5th percentile	Infants (3–6 months)	1	0.07	0.98	0.07	0.98	0.07	0.98
	Infants (6–12 months)	4	0.03	0.78	0.05	0.89	0.14	0.96
	Toddlers	7	0.06	0.82	0.08	0.89	0.13	0.97

LB: lower bound; N: number of surveys; UB: upper bound.

^aThe 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations, respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.